Literature DB >> 6979752

Studies of the blood plasminogen activator induced by 1-desamino-8-D-arginine vasopressin with observations in von Willebrand's disease.

L Holmberg, I M Nilsson, P Wallén, B Astedt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6979752     DOI： 10.3181/00379727-170-41407

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  6 in total

1.  In vitro stimulation of plasminogen activator release from vein walls by adrenaline.

Authors:  A Kjaeldgaard; M Kjaeldgaard
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

Review 2.  Von Willebrand's disease.

Authors:  I M Nilsson; S Lethagen
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

3.  Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.

Authors:  R I Levin; P C Harpel; D Weil; T S Chang; D B Rifkin
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

4.  Immunological comparison between human and rat plasminogen activators in blood and the vessel wall.

Authors:  A Kjaeldgaard; B Larsson; B Astedt
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

5.  Immunological characterisation of plasminogen activators in the human vessel wall.

Authors:  H Ljungnér; L Holmberg; A Kjeldgaard; I M Nilsson; B Astedt
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

6.  Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.

Authors:  I M Nilsson; H Ljungnér; L Tengborn
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.